Fibulin-4 conducts proper elastogenesis via interaction with cross-linking enzyme lysyl oxidase

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 45, 2009, Pages 19029-19034

  Horiguchi, Masahito ^a   Inoue, Tadashi ^b   Ohbayashi, Tetsuya ^c   Hirai, Maretoshi ^d   Noda, Kazuo ^a,b   Marmorstein, Lihua Y ^e   Yabe, Daisuke ^f   Takagi, Kyoko ^b,g   Akama, Tomoya O ^b   Kita, Toru ^a,h   Kimura, Takeshi ^a   Nakamura, Tomoyuki ^b  

^a KYOTO UNIVERSITY   (Japan)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

^c TOTTORI UNIVERSITY   (Japan)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^e UNIVERSITY OF ARIZONA   (United States)

^f KANSAI ELECTRIC POWER CO   (Japan)

^g Rohto Pharmaceutical Company Limited   (Japan)

^h KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

Author keywords

Development; Elastin; Extracellular matrix

Indexed keywords

CRE RECOMBINASE; ELASTIN; FIBULIN; FIBULIN 4; FIBULIN 5; PROTEIN LYSINE 6 OXIDASE; TROPOELASTIN; UNCLASSIFIED DRUG;

ALLELE; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA ANEURYSM; ARTERIAL STIFFNESS; ARTICLE; ASCENDING AORTA; CONTROLLED STUDY; DIAPHRAGM RUPTURE; ELASTIC FIBER; ELASTICITY; ELECTRON MICROSCOPY; GENE DELETION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SMOOTH MUSCLE; SMOOTH MUSCLE FIBER;

ANIMALS; ARTERIES; ELASTIN; EXTRACELLULAR MATRIX PROTEINS; GENE DELETION; IMMUNOHISTOCHEMISTRY; MICE; MICE, KNOCKOUT; MICROSCOPY, ELECTRON; POLYMERASE CHAIN REACTION; PROTEIN BINDING; PROTEIN-LYSINE 6-OXIDASE;

MUS;

EID: 73149111728     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0908268106     Document Type: Article

References (47)

1. Rosenbloom J, Abrams WR, Mecham R (1993) Extracellular matrix 4: The elastic fiber. FASEB J 7:1208-1218.
2. Bailey AJ (2001) Molecular mechanisms of ageing in connective tissues. Mech Ageing Dev 122:735-755.
3. Pasquali-Ronchetti I, Baccarani-Contri M (1997) Elastic fiber during development and aging. Microsc Res Tech 38:428-435.
4. Sakai LY, Keene DR, Engvall E (1986) Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils. J Cell Biol 103:2499-2509.
5. Zhang H, et al. (1994) Structure and expression of fibrillin-2, a novel microfibrillar component preferentially located in elastic matrices. J Cell Biol 124:855-863.
6. Ramirez F, Sakai LY, Dietz HC, Rifkin DB (2004) Fibrillin microfibrils: Multipurpose extracellular networks in organismal physiology. Physiol Genomics 19:151-154.
7. Gray WR, Sandberg LB, Foster JA (1973) Molecular model for elastin structure and function. Nature 246:461-466.
8. Wagenseil JE, Mecham RP (2007) New insights into elastic fiber assembly. Birth Defects Res C Embryo Today 81:229-240.
9. Gibson MA, et al. (1996) Further characterization of proteins associated with elastic fiber microfibrils including the molecular cloning of MAGP-2 (MP25). J Biol Chem 271:1096-1103.
10. Gibson MA, Hughes JL, Fanning JC, Cleary EG (1986) The major antigen of elastin-associated microfibrils is a 31-kDa glycoprotein. J Biol Chem 261:11429-11436.
11. Bressan GM, Castellani I, Colombatti A, Volpin D (1983) Isolation and characterization of a 115,000-dalton matrix-associated glycoprotein from chick aorta. J Biol Chem 258:13262-13267.
12. Bressan GM, et al. (1993) Emilin, a component of elastic fibers preferentially located at the elastin-microfibrils interface. J Cell Biol 121:201-212.
13. Huang G, et al. (2009) Fibronectin binds and enhances the activity of bone morphogenetic protein 1. J Biol Chem 284:25879-25888.
14. Sabatier L, et al. (2009) Fibrillin assembly requires fibronectin. Mol Biol Cell 20:846-858.
15. Hirai M, et al. (2007) Latent TGF-beta-binding protein 2 binds to DANCE/fibulin-5 and regulates elastic fiber assembly. EMBO J 26:3283-3295.
16. Sterner-Kock A, et al. (2002) Disruption of the gene encoding the latent transforming growth factor-beta binding protein 4 (LTBP-4) causes abnormal lung development, cardiomyopathy, and colorectal cancer. Genes Dev 16:2264-2273.
17. Argraves WS, Greene LM, Cooley MA, Gallagher WM (2003) Fibulins: Physiological and disease perspectives. EMBO Rep 4:1127-1131.
18. de Vega S, et al. (2007) TM14 is a new member of the fibulin family (fibulin-7) that interacts with extracellular matrix molecules and is active for cell binding. J Biol Chem 282:30878-30888.
19. Nakamura T, et al. (1999) DANCE, a novel secreted RGD protein expressed in developing, atherosclerotic, and balloon-injured arteries. J Biol Chem 274:22476-22483.
20. Lecka-Czernik B, Lumpkin CK, Jr, Goldstein S (1995) An overexpressed gene transcript in senescent and quiescent human fibroblasts encoding a novel protein in the epidermal growth factor-like repeat family stimulates DNA synthesis. Mol Cell Biol 15:120-128.
21. Stone EM, et al. (1999) A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy. Nat Genet 22:199-202.
22. McLaughlin PJ, et al. (2007) Lack of fibulin-3 causes early aging and herniation, but not macular degeneration in mice. Hum Mol Genet 16:3059-3070.
23. Kowal RC, Richardson JA, Miano JM, Olson EN (1999) EVEC, a novel epidermal growth factor-like repeat-containing protein upregulated in embryonic and diseased adult vasculature. Circ Res 84:1166-1176.
24. Nakamura T, et al. (2002) Fibulin-5/DANCE is essential for elastogenesis in vivo. Nature 415:171-175.
25. Yanagisawa H, et al. (2002) Fibulin-5 is an elastin-binding protein essential for elastic fibre development in vivo. Nature 415:168-171.
26. Hirai M, et al. (2007) Fibulin-5/DANCE has an elastogenic organizer activity that is abrogated by proteolytic cleavage in vivo. J Cell Biol 176:1061-1071.
27. Loeys B, et al. (2002) Homozygosity for amissense mutation in fibulin-5 (FBLN5) results in a severe form of cutis laxa. Hum Mol Genet 11:2113-2118.
28. Markova D, et al. (2003) Genetic heterogeneity of cutis laxa: A heterozygous tandem duplication within the fibulin-5 (FBLN5) gene. Am J Hum Genet 72:998-1004.
29. Stone EM, et al. (2004) Missense variations in the fibulin 5 gene and age-related macular degeneration. N Engl J Med 351:346-353.
30. Giltay R, Timpl R, Kostka G (1999) Sequence, recombinant expression and tissue localization of two novel extracellular matrix proteins, fibulin-3 and fibulin-4. Matrix Biol 18:469-480.
31. McLaughlin PJ, et al. (2006) Targeted disruption of fibulin-4 abolishes elastogenesis and causes perinatal lethality in mice. Mol Cell Biol 26:1700-1709.
32. Hucthagowder V, et al. (2006) Fibulin-4: A novel gene for an autosomal recessive cutis laxa syndrome. Am J Hum Genet 78:1075-1080.
33. Xiang Y, et al. (2006) Fibulin-4 is a target of autoimmunity predominantly in patients with osteoarthritis. J Immunol 176:3196-3204.
34. Lucero HA, Kagan HM (2006) Lysyl oxidase: An oxidative enzyme and effector of cell function. Cell Mol Life Sci 63:2304-2316.
35. Kagan HM, Li W (2003) Lysyl oxidase: Properties, specificity, and biological roles inside and outside of the cell. J Cell Biochem 88:660-672.
36. Uzel MI, et al. (2001) Multiple bone morphogenetic protein 1-related mammalian metalloproteinases process pro-lysyl oxidase at the correct physiological site and control lysyl oxidase activation in mouse embryo fibroblast cultures. J Biol Chem 276:22537-22543.
37. Thomassin L, et al. (2005) The Pro-regions of lysyl oxidase and lysyl oxidase-like 1 are required for deposition onto elastic fibers. J Biol Chem 280:42848-42855.
38. Hornstra IK, et al. (2003) Lysyl oxidase is required for vascular and diaphragmatic development in mice. J Biol Chem 278:14387-14393.
39. Maki JM, et al. (2002) Inactivation of the lysyl oxidase gene Lox leads to aortic aneurysms, cardiovascular dysfunction, and perinatal death in mice. Circulation 106:2503-2509.
40. Holtwick R, et al. (2002) Smooth muscle-selective deletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure. Proc Natl Acad Sci USA 99:7142-7147.
41. Li L, Miano JM, Mercer B, Olson EN (1996) Expression of the SM22alpha promoter in transgenic mice provides evidence for distinct transcriptional regulatory programs in vascular and visceral smooth muscle cells. J Cell Biol 132:849-859.
42. Hanada K, et al. (2007) Perturbations of vascular homeostasis and aortic valve abnormalities in fibulin-4 deficient mice. Circ Res 100:738-746.
43. Dendouga N, et al. (2005) Disruption of murine Mus81 increases genomic instability and DNA damage sensitivity but does not promote tumorigenesis. Mol Cell Biol 25:7569-7579.
44. Dasouki M, et al. (2007) Compound heterozygous mutations in fibulin-4 causing neonatal lethal pulmonary artery occlusion, aortic aneurysm, arachnodactyly, and mild cutis laxa. Am J Med Genet A 143A:2635-2641.
45. Choudhury R, et al. (2009) Differential regulation of elastic fiber formation by fibulins -4 AND -5. J Biol Chem 284:24553-24567.
46. Morita M, et al. (2003) HLF/HIF-2alpha is a key factor in retinopathy of prematurity in association with erythropoietin. EMBO J 22:1134-1146.
47. Niwa H, et al. (1993) An efficient gene-trap method using poly A trap vectors and characterization of gene-trap events. J Biochem 113:343-349.